Host TS Wiley interviews mainstream oncologist Julie Taguchi from Sansum Clinic in Santa Barbara, California on the memory loss attendant with estrogen deprivation and chemotherapy. In the interview they also cover the validity of big pharma testing on oncology drugs versus no treatment at all. This is a candid and frank interview with someone on the inside of the standard of care in breast cancer treatment. This isn’t a show you want to miss!

Subscribe with your favorite podcast player

The post A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?” appeared first on WebTalkRadio.net.